Ligand validation:1FDU

EST: ESTRADIOL

EST is a Ligand Of Interest in 1FDU designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1FDU_EST_C_353	12%	33%	0.294	0.828	0.79	1.83	-	9	3	0	100%	0.9505
1FDU_EST_A_351	11%	22%	0.301	0.815	0.81	2.37	1	14	10	0	100%	1
1FDU_EST_D_352	9%	19%	0.299	0.788	1.13	2.28	1	13	6	0	100%	1
1FDU_EST_B_354	5%	16%	0.312	0.73	1.1	2.55	1	11	6	0	100%	1
1IOL_EST_A_400	57%	27%	0.143	0.919	1.9	1.05	7	3	1	0	100%	1
1FDW_EST_A_350	6%	40%	0.368	0.796	0.86	1.48	-	7	4	0	100%	0.5
1A27_EST_A_350	0%	34%	0.517	0.359	0.92	1.67	1	9	5	0	100%	0.5
3OLS_EST_B_600	97%	23%	0.064	0.982	1.63	1.55	3	6	0	0	100%	1
3OLL_EST_A_600	96%	16%	0.07	0.98	2.07	1.63	9	9	0	0	100%	1
7NEL_EST_B_601	94%	46%	0.076	0.975	1.01	1.07	2	2	0	0	100%	1
5DXG_EST_A_1000	92%	27%	0.078	0.969	1.65	1.29	5	4	1	0	100%	1
3UUD_EST_A_600	92%	27%	0.071	0.961	1.64	1.33	5	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.